gentian violet has been researched along with Adverse Drug Event in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Evans, S; Freedberg, KA; Ghannoum, MA; Hakim, J; Kumwenda, J; Lee, A; Masheto, G; Mukherjee, PK; Patton, LL; Pho, MT; Salata, RA; Sawe, F; Shiboski, CH | 1 |
| Arbiser, JL | 1 |
| Wegmann, T | 1 |
1 trial(s) available for gentian violet and Adverse Drug Event
| Article | Year |
|---|---|
Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis, Oral; Drug-Related Side Effects and Adverse Reactions; Female; Gentian Violet; Health Care Costs; HIV Infections; Humans; Male; Middle Aged; Nystatin; Single-Blind Method; Treatment Outcome; Young Adult | 2017 |
2 other study(ies) available for gentian violet and Adverse Drug Event
| Article | Year |
|---|---|
Gentian violet is safe.
Topics: Animals; Cohort Studies; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Gentian Violet; Humans; Leukoplakia, Hairy; Mice; Risk Assessment; Sensitivity and Specificity | 2009 |
[Treatment of systemic mycosis (author's transl)].
Topics: Adrenal Cortex Hormones; Antifungal Agents; Benzene Derivatives; Cytosine; Drug-Related Side Effects and Adverse Reactions; Fluorine; Gentian Violet; Histoplasmosis; Humans; Iatrogenic Disease; Imidazoles; Immunosuppressive Agents; Mycoses; Natamycin; Nystatin; Sulfonamides | 1973 |